Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Tanaka

Assessment of Palindromes as Platforms for DNA Amplification in Breast Cancer

Genome Research

Genetics

2011

English

Development of Engineered T Cells Expressing a Chimeric CD16-CD3 Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia

Clinical Cancer Research

Cancer Research

Oncology

2016

English

Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis

Cancer Research

Oncology

2013

English

Dual Regulation of ETTIN (ARF3) Gene Expression by AS1-AS2, Which Maintains the DNA Methylation Level, Is Involved in Stabilization of Leaf Adaxial-Abaxial Partitioning in Arabidopsis

Development (Cambridge)

Developmental Biology

Molecular Biology

2013

English

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

Journal of Thoracic Oncology

English

OA11 First-Line Nivolumab + Ipilimumab in Asian Patients With Advanced NSCLC and High TMB (≥10 Mut/Mb): Results From CheckMate 227

Journal of Thoracic Oncology

English

P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.01-34 Docetaxel Plus Ramucirumab With Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)

Journal of Thoracic Oncology

English

P2.15-004 Underrepresentation of Elderly Patients With ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)

Journal of Thoracic Oncology

English

P3.13-22 Real World Study of Afatinib in First-Line or Re-Challenge Setting for Patients With EGFR Mutant Non-Small Cell Lung Cancer.

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Tanaka

Assessment of Palindromes as Platforms for DNA Amplification in Breast Cancer

Development of Engineered T Cells Expressing a Chimeric CD16-CD3 Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia

Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis

Dual Regulation of ETTIN (ARF3) Gene Expression by AS1-AS2, Which Maintains the DNA Methylation Level, Is Involved in Stabilization of Leaf Adaxial-Abaxial Partitioning in Arabidopsis

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

OA11 First-Line Nivolumab + Ipilimumab in Asian Patients With Advanced NSCLC and High TMB (≥10 Mut/Mb): Results From CheckMate 227

P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer

P1.01-34 Docetaxel Plus Ramucirumab With Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)

P2.15-004 Underrepresentation of Elderly Patients With ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)

P3.13-22 Real World Study of Afatinib in First-Line or Re-Challenge Setting for Patients With EGFR Mutant Non-Small Cell Lung Cancer.